These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17373336)

  • 1. Comparison of dynamic FDG-microPET study in a rabbit turpentine-induced inflammatory model and in a rabbit VX2 tumor model.
    Hamazawa Y; Koyama K; Okamura T; Wada Y; Wakasa T; Okuma T; Watanabe Y; Inoue Y
    Ann Nucl Med; 2007 Jan; 21(1):47-55. PubMed ID: 17373336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of FDG-microPET for early evaluation of therapeutic effects on VX2 rabbit carcinoma.
    Ishii K; Hosono MN; Wada Y; Maeda M; Kondo S; Takada Y; Tada T; Okamura T; Watanabe Y; Inoue Y
    Ann Nucl Med; 2006 Feb; 20(2):123-30. PubMed ID: 16615421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of experimental rabbit tumour and inflammation model with 18F-FDG PET/CT.
    Liu P; Huang G; Dong S; Wan L
    Nuklearmedizin; 2009; 48(4):153-8. PubMed ID: 19384450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-MicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits.
    Ohira T; Okuma T; Matsuoka T; Wada Y; Nakamura K; Watanabe Y; Inoue Y
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):114-20. PubMed ID: 18696151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer.
    Kondo S; Hosono MN; Wada Y; Ishii K; Matsumura A; Takada Y; Tashiro M; Okamura T; Fukuda H; Yamada R; Watanabe Y; Inoue Y
    Ann Nucl Med; 2004 Feb; 18(1):51-7. PubMed ID: 15072184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
    Liu RS; Chou TK; Chang CH; Wu CY; Chang CW; Chang TJ; Wang SJ; Lin WJ; Wang HE
    Nucl Med Biol; 2009 Apr; 36(3):305-12. PubMed ID: 19324276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
    Okuma T; Matsuoka T; Okamura T; Wada Y; Yamamoto A; Oyama Y; Koyama K; Nakamura K; Watanabe Y; Inoue Y
    J Nucl Med; 2006 Aug; 47(8):1351-8. PubMed ID: 16883016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor.
    Koyama K; Okamura T; Kawabe J; Ozawa N; Higashiyama S; Ochi H; Yamada R
    Ann Nucl Med; 2002 May; 16(3):169-76. PubMed ID: 12126041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
    Zhao S; Kuge Y; Kohanawa M; Takahashi T; Zhao Y; Yi M; Kanegae K; Seki K; Tamaki N
    J Nucl Med; 2008 Jan; 49(1):135-41. PubMed ID: 18077525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology.
    Zheng J; Allen C; Serra S; Vines D; Charron M; Jaffray DA
    Contrast Media Mol Imaging; 2010; 5(3):147-54. PubMed ID: 20586032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice.
    Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK
    Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model.
    Song SL; Liu JJ; Huang G; Wang ZH; Song YY; Sun XG; Chen T
    J Nucl Med; 2008 Feb; 49(2):303-9. PubMed ID: 18199614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic evaluation of 18F-FDG uptake by microPET and whole-body autoradiography in a fibrosarcoma-bearing mouse model.
    Chang CH; Fan KH; Chen TJ; Hsu WC; Jan ML; Tsai TH; Kao PF; Chen CF; Fu YK; Lee TW
    J Formos Med Assoc; 2004 Nov; 103(11):876-81. PubMed ID: 15549159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
    van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
    J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic observation of the radiosensitive effect of irisquinone on rabbit VX2 lung transplant tumors by using fluorine-18-deoxyglucose positron emission tomography/computed tomography.
    Xu H; Sun G; Wang H; Yue Q; Tang H; Wu Q
    Nucl Med Commun; 2013 Mar; 34(3):220-8. PubMed ID: 23276827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
    Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
    J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M
    J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of tumor metastasis by an FDG-microPet/microCT dual-imaging modality in a lung carcinoma-bearing mouse model.
    Chang CH; Jan ML; Fan KH; Wang HE; Tsai TH; Chen CF; Fu YK; Lee TW
    Anticancer Res; 2006; 26(1A):159-66. PubMed ID: 16475693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.